GILENYA 0.5 mg, hard capsule 7 capsules
Active ingredients: Fingolimod hydrochloride, Fingolimod
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule7 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- GILENYA 0,5 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- 7 plaquettes thermoformées unidoses perforées PVC PVDC aluminium de 1 gélule
- Marketing authorisation holder
- NOVARTIS EUROPHARM (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Dec 2011
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60728597CIP74177853CIP133400941778537Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FINGOLIMODgélule | 0,5 mg · une gélule | FT |
| CHLORHYDRATE DE FINGOLIMODgélule | 0,56 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.